Emma is Head of Biologics QC Network at Roche Pharma and is accountable for the Biologics QC network strategy including lifecycle management of methods, analytical technology and analytical controls systems, stability program management, raw materials management, and adventitious agent testing. Prior to this Emma was Head of Quality Risk Management and led the design, deployment, and governance of a harmonized QRM program at Roche Pharma. She has applied her extensive QRM experience in actively influencing industry QRM best practices, leading QRM activities for PDA, providing QRM training to regulatory authorities and at industry forums like PDA, ISPE etc. Emma is currently leading PDA’s Task Force on Drug Shortages. She also led the development and authorship of PDA TR54 “Implementation of Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations”. Her other experience includes validation, change control, QC testing, and laboratory controls management. Before joining Genentech in 2005, Emma worked at Guidant Corporation and ALZA/Johnson & Johnson. Emma has an M.S. in Pharmaceutical Sciences from University of Connecticut, an M.S. in Medicinal & Pharmaceutical Chemistry, and a B.S. in Pharmacy, both from University of Indore, India.